Profile data is unavailable for this security.
About the company
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.
- Revenue in GBP (TTM)1.40m
- Net income in GBP-14.39m
- Incorporated2015
- Employees35.00
- LocationBelluscura PLC15 Fetter LaneLONDON EC4A 1BWUnited KingdomGBR
- Phone+1 21 4396 8313
- Websitehttps://www.belluscura.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Genedrive PLC | 272.00k | -5.00m |
Abingdon Health PLC | 6.14m | -1.27m |
Inspiration Healthcare Group PLC | 34.30m | -9.76m |
Belluscura PLC | 1.40m | -14.39m |
Polarean Imaging PLC | 1.45m | -6.61m |
Ondine Biomedical Inc | 906.17k | -7.92m |
ANGLE plc | 2.02m | -18.03m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Dowgate Wealth Ltd.as of 04 Apr 2024 | 7.48m | 4.44% |
Lombard Odier Asset Management (Europe) Ltd.as of 15 Nov 2023 | 6.45m | 3.83% |
Gresham House Asset Management Ltd. (Investment Management)as of 31 May 2024 | 4.03m | 2.39% |
Rathbones Asset Management Ltd.as of 09 Feb 2024 | 2.23m | 1.32% |
Avellemy Ltd.as of 30 Sep 2024 | 575.71k | 0.34% |